newsfilter
← Latest News
ACCESS Newswire·

Ensysce Biosciences Reports First Quarter 2025 Financial Results

Receives U.S. Patent for Groundbreaking Treatment for Opioid Use DisorderClinical Trial on Novel Analgesic, PF614-MPAR, Demonstrates Overdose Protection SAN DIEGO, CA / ACCESS Newswire / May 13, 2025 / Ensysce